What to tell parents about CA-MRSA

Creech, C. Buddy
July 2011
Infectious Disease News;Jul2011, Vol. 24 Issue 7, p32
The author reflects on commonly asked questions regarding the prevention of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA).


Related Articles

  • A Rapidly Emerging Ocular Adnexal Villain. Takle Jr., Leiv M.; Bernardino, C. Robert // Review of Ophthalmology;Apr2007 Part 1 of 2, Vol. 14 Issue 4, p115 

    The article offers information on community-acquired methicillin resistant staphylococcus aureus (CA-MRSA), an emerging public health problem in the U.S. Community-acquired resistant infections are both public health, diagnostic and therapeutic challenge for ophthalmologists. Several strains of...

  • Strict protocols prevent spread of MRSA.  // Hospital Home Health;Nov2009, Vol. 26 Issue 11, p124 

    The article reports on the specific infection control protocols implemented by employees at Northwest Community Home Care in Arlington Heights, Illinois to prevent the spread of methicillin-resistant staphylococcus aureas (MRSA).

  • Guides issued to treat MRSA. Gustafson, Mary // McKnight's Long-Term Care News;Feb2011, Vol. 32 Issue 2, p3 

    The article focuses on the move of the Infectious Diseases Society of America to release its first set of comprehensive guidelines for treating methicillin-resistant staphylococcus aureus (MRSA).

  • Consumer alert: Antibiotic resistance is growing!  // People's Medical Society Newsletter;Aug97, Vol. 16 Issue 4, p1 

    Deals with the effectivity of vancomycin to Staphylococcus aureus, the bacterium that commonly cause nosocomial infection. Study conducted by Centers for Disease Control (CDC) involving a child in Japan who developed an infection; CDC plan on issuing guidelines for vancomycin-resistant bacteria;...

  • Update: Staphylococcus aureus with reduced susceptibility to vancomycin--United State, 1997. Martin, R.; Wilcox, K.R. // MMWR: Morbidity & Mortality Weekly Report;9/5/1997, Vol. 46 Issue 35, p813 

    Investigates Staphylococcus aureus with reduced susceptibility to vancomycin in the United States. Use of vancomycin to fight methicillin-resistant Staphylococcus aureus; Information on case studies; Details on the study.

  • Cross-Reactive Antibodies Prevent the Lethal Effects of Staphylococcus aureus Superantigens. Bavari, Sina; Ulrich, Robert G.; LeClaire, Ross D. // Journal of Infectious Diseases;10/1/99, Vol. 180 Issue 4, p1365 

    Examines whether common antigenic epitopes were present and whether 1 bacterial SAg could act as antibodies to prevent the lethal effects of Staphylococcus aureus infections. Improvement in survival observed when immunized mice were challenged with a heterologous toxin; Titters found against...

  • Protection against Staphylococcus aureus Sepsis by Vaccination with Recombinant Staphylococcal Enterotoxin A Devoid of Superantigenicity. Nilsson, Ing-Marie; Verdrengh, Margareta; Ulrich, Robert G.; Bavari, Sina; Tarkowski, Andrzej // Journal of Infectious Diseases;10/1/99, Vol. 180 Issue 4, p1370 

    Assesses whether recombitant staphylococcal enterotoxin A (SEA) could protect against septicemia caused by staphylococcus aureus infections. Transfer of SEA-specific antibodies to naive mice resulting in good protection against mortality.

  • Progress to bring MRSA under control worldwide. McKnight, Whitney // Infectious Disease News;Jun2011, Vol. 24 Issue 6, p46 

    The article presents updates on the progress of the worldwide fight against Staphylococcus aureus.

  • INFECTION CONTROL DRIVE.  // Nursing Standard;6/30/2010, Vol. 24 Issue 43, p9 

    The article focuses on a programme piloted by St John's Hospital in West Lothian, Scotland that aims to prevent the spread of infections including clostridium difficile and methicillin-resistant Staphylococcus aureus (MRSA).


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics